DAYBU

This brand name is authorized in Austria, Lithuania.

Active ingredients

The drug DAYBU contains one active pharmaceutical ingredient (API):

1	Trofinetide UNII Z2ME8F52QL - TROFINETIDE
	Trofinetide is a synthetic analogue of the N-terminal tripeptide of insulin-like growth factor 1. The precise molecular mechanism of trofinetide activity in the treatment of neurobehavioural symptoms of Rett syndrome is not known.
	Read more about Trofinetide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DAYBU Oral solution	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N07XX24		N Nervous system → N07 Other nervous system drugs → N07X Other nervous system drugs → N07XX Other nervous system drugs
Discover more medicines within N07XX24

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
LT	Valstybinė vaistų kontrolės tarnyba	1108291